These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24760640)

  • 21. Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach.
    Agaimy A; Vassos N; Märkl B; Meidenbauer N; Köhler J; Spatz J; Hohenberger W; Haller F; Croner RS; Schneider-Stock R; Matzel K
    Int J Colorectal Dis; 2013 Aug; 28(8):1057-64. PubMed ID: 23404343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A Case of Rectal Gastrointestinal Stromal Tumor(GIST)with Long-Term Survival Treated with Multidisciplinary Therapy].
    Tendo M; Hori T; Iimori N; Deguchi S; Sakimura C; Masuda G; Nakao S; Nakata B; Ohira M; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2288-2290. PubMed ID: 30692440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of multiple metastatic giant rectal GIST successfully treated with surgical intervention after administration of imatinib mesylate].
    Kitamura D; Ikeda K; Unotoro J; Seki E; Gonda H; Izumi H
    Nihon Shokakibyo Gakkai Zasshi; 2013 Jan; 110(1):74-80. PubMed ID: 23303232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
    Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
    [No Abstract]   [Full Text] [Related]  

  • 26. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
    Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
    Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and prognosis of different treatments on 63 patients with small intestinal gastrointestinal stromal tumors].
    Liu L; Liu Y; Wu X; Chen L; Xu W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):344-7. PubMed ID: 24760642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum.
    Fujimoto Y; Akiyoshi T; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    Int J Colorectal Dis; 2014 Jan; 29(1):111-6. PubMed ID: 24018650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transanal endoscopic microsurgery following treatment with imatinib : a case report of a patient with a rectal gastrointestinal stromal tumor.
    Tielen R; Bremers AJ; van der Graaf WT; Flucke UE; de Wilt JH
    Acta Chir Belg; 2015; 115(2):166-9. PubMed ID: 26021953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum.
    Kyo K; Azuma M; Okamoto K; Nishiyama M; Shimamura T; Maema A; Kanamaru H; Shirakawa M; Nakamura T; Shinmura K; Koda K; Yokoyama H
    World J Surg Oncol; 2016 Mar; 14():68. PubMed ID: 26957123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
    Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
    JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
    Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z
    World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognosis analysis of 216 cases of gastrointestinal stromal tumor].
    Liu LC; Xu WT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):255-8. PubMed ID: 22454172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and prognosis of rectal gastrointestinal stromal tumors: an analysis of registry data.
    Yasui M; Tsujinaka T; Mori M; Takahashi T; Nakashima Y; Nishida T;
    Surg Today; 2017 Oct; 47(10):1188-1194. PubMed ID: 28421351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
    Li J; Dang YZ; Gao J; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.
    Aparicio T; Boige V; Sabourin JC; Crenn P; Ducreux M; Le Cesne A; Bonvalot S
    Eur J Surg Oncol; 2004 Dec; 30(10):1098-103. PubMed ID: 15522557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adherence to adjuvant with therapy imatinib in patients with gastrointestinal stromal tumor: a national multi-center cross-sectional study].
    Zhang P; Zhang J; Zhang B; Yang WC; Hu JB; Sun XF; Zhai G; Qian HR; Li Y; Xu H; Feng F; Wu XY; Liu HL; Liu HJ; Qiu HB; Wu XJ; Zhou YB; Shen KT; Kou YW; Fu Y; Jie ZG; Zou XM; Cao H; Gao ZD; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):775-782. PubMed ID: 34530558
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases].
    Yang J; Yu J; Ma Z; Kang W; Tian S; Ye X
    Zhonghua Wai Ke Za Zhi; 2015 Apr; 53(4):274-9. PubMed ID: 26269161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.